NASDAQ:BRKR - Bruker Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$31.36 -0.29 (-0.92 %)
(As of 12/14/2018 07:09 AM ET)
Previous Close$31.65
Today's Range$31.15 - $32.22
52-Week Range$28.13 - $36.49
Volume591,941 shs
Average Volume705,097 shs
Market Capitalization$4.96 billion
P/E Ratio25.92
Dividend Yield0.51%
Beta1.39
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, and defect-detection equipment for semiconductor process control, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments and spark optical emission spectroscopy systems. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology and diagnostics, chemical, food and beverage, clinical, polymer, nanotechnology, semiconductor, and industrial companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, agriculture, food and beverage safety, environmental and clinical microbiology laboratories, hospitals, and government departments and agencies; and raw material manufacturers, and other businesses involved in materials analysis. It markets its products through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts.

Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
Current SymbolNASDAQ:BRKR
Previous Symbol
CUSIP11679410
Phone978-663-3660

Debt

Debt-to-Equity Ratio0.27
Current Ratio2.24
Quick Ratio1.32

Price-To-Earnings

Trailing P/E Ratio25.92
Forward P/E Ratio22.40
P/E Growth1.93

Sales & Book Value

Annual Sales$1.77 billion
Price / Sales2.78
Cash Flow$1.6333 per share
Price / Cash Flow19.20
Book Value$4.72 per share
Price / Book6.64

Profitability

EPS (Most Recent Fiscal Year)$1.21
Net Income$78.60 million
Net Margins5.24%
Return on Equity27.46%
Return on Assets11.52%

Miscellaneous

Employees6,200
Outstanding Shares156,570,000
Market Cap$4.96 billion
OptionableOptionable

Bruker (NASDAQ:BRKR) Frequently Asked Questions

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker announced a quarterly dividend on Friday, November 9th. Investors of record on Monday, December 3rd will be paid a dividend of $0.04 per share on Friday, December 21st. This represents a $0.16 dividend on an annualized basis and a yield of 0.51%. The ex-dividend date is Friday, November 30th. View Bruker's Dividend History.

How will Bruker's stock buyback program work?

Bruker declared that its Board of Directors has initiated a share repurchase plan on Sunday, June 4th 2017, which authorizes the company to buyback $225,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to buy shares of its stock through open market purchases. Shares buyback plans are generally an indication that the company's board of directors believes its stock is undervalued.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) issued its quarterly earnings data on Thursday, November, 1st. The medical research company reported $0.37 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.30 by $0.07. The medical research company had revenue of $466.60 million for the quarter, compared to analysts' expectations of $451.88 million. Bruker had a net margin of 5.24% and a return on equity of 27.46%. The firm's quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.29 EPS. View Bruker's Earnings History.

When is Bruker's next earnings date?

Bruker is scheduled to release their next quarterly earnings announcement on Thursday, February 14th 2019. View Earnings Estimates for Bruker.

What guidance has Bruker issued on next quarter's earnings?

Bruker issued an update on its FY18 earnings guidance on Thursday, November, 1st. The company provided EPS guidance of $1.36-1.40 for the period, compared to the Thomson Reuters consensus estimate of $1.37. The company issued revenue guidance of $1.88-1.89 billion (+6.5-7%), compared to the consensus revenue estimate of $1.88 billion.

What price target have analysts set for BRKR?

7 brokers have issued 1 year price objectives for Bruker's stock. Their predictions range from $30.00 to $42.00. On average, they anticipate Bruker's stock price to reach $34.7143 in the next twelve months. This suggests a possible upside of 10.7% from the stock's current price. View Analyst Price Targets for Bruker.

What is the consensus analysts' recommendation for Bruker?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 2 sell ratings, 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Bruker.

Has Bruker been receiving favorable news coverage?

Press coverage about BRKR stock has trended positive this week, according to InfoTrie. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Bruker earned a news sentiment score of 3.0 on InfoTrie's scale. They also gave headlines about the medical research company a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an effect on the stock's share price in the near future.

Who are some of Bruker's key competitors?

Who are Bruker's key executives?

Bruker's management team includes the folowing people:
  • Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 58)
  • Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 56)
  • Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 63)
  • Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 60)
  • Stacey Desrochers, Treasurer & Director of Investor Relations

Who are Bruker's major shareholders?

Bruker's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc (6.52%), Vanguard Group Inc. (6.52%), FMR LLC (4.68%), BlackRock Inc. (3.41%), Acadian Asset Management LLC (2.98%) and AQR Capital Management LLC (1.44%). Company insiders that own Bruker stock include Frank H Laukien, Ingen Chris Van, Mark Munch and Richard Kniss. View Institutional Ownership Trends for Bruker.

Which major investors are selling Bruker stock?

BRKR stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace North America L.P., Renaissance Technologies LLC, First Quadrant L P CA, Pictet Asset Management Ltd., Allianz Asset Management GmbH, MERIAN GLOBAL INVESTORS UK Ltd, Prudential Financial Inc. and First Trust Advisors LP. View Insider Buying and Selling for Bruker.

Which major investors are buying Bruker stock?

BRKR stock was bought by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Marshall Wace LLP, AQR Capital Management LLC, Panagora Asset Management Inc., Morgan Stanley, Man Group plc, Fuller & Thaler Asset Management Inc. and Epoch Investment Partners Inc.. View Insider Buying and Selling for Bruker.

How do I buy shares of Bruker?

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $31.36.

How big of a company is Bruker?

Bruker has a market capitalization of $4.96 billion and generates $1.77 billion in revenue each year. The medical research company earns $78.60 million in net income (profit) each year or $1.21 on an earnings per share basis. Bruker employs 6,200 workers across the globe.

What is Bruker's official website?

The official website for Bruker is http://www.bruker.com.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]


MarketBeat Community Rating for Bruker (NASDAQ BRKR)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  524 (Vote Outperform)
Underperform Votes:  578 (Vote Underperform)
Total Votes:  1,102
MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe BRKR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRKR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/14/2018 by MarketBeat.com Staff

Featured Article: Day Trading

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel